Home > National Drug Code (NDC) > Deferoxamine

Deferoxamine - 63323-597-10 - (DEFEROXAMINE MESYLATE)

Alphabetical Index


Drug Information of Deferoxamine

Product NDC: 63323-597
Proprietary Name: Deferoxamine
Non Proprietary Name: DEFEROXAMINE MESYLATE
Active Ingredient(s): 95    mg/mL & nbsp;   DEFEROXAMINE MESYLATE
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Deferoxamine

Product NDC: 63323-597
Labeler Name: APP Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA078718
Marketing Category: ANDA
Start Marketing Date: 20091215

Package Information of Deferoxamine

Package NDC: 63323-597-10
Package Description: 1 VIAL in 1 BOX (63323-597-10) > 5.3 mL in 1 VIAL

NDC Information of Deferoxamine

NDC Code 63323-597-10
Proprietary Name Deferoxamine
Package Description 1 VIAL in 1 BOX (63323-597-10) > 5.3 mL in 1 VIAL
Product NDC 63323-597
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name DEFEROXAMINE MESYLATE
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20091215
Marketing Category Name ANDA
Labeler Name APP Pharmaceuticals, LLC
Substance Name DEFEROXAMINE MESYLATE
Strength Number 95
Strength Unit mg/mL
Pharmaceutical Classes Iron Chelating Activity [MoA],Iron Chelator [EPC]

Complete Information of Deferoxamine


General Information